摘要 |
This invention arises from the discovery that compounds capable of blocking cellular monocarboxylate transport can inhibit lymphocyte proliferation, offering up these compounds as therapeutic agents in various immune-mediated disorders and cancers. Accordingly, this invention relates, inter alia, to methods of screening compounds for their ability to treat certain cancers and immune-mediated disorders, particularly transplant rejection and rheumatoid arthritis. The invention also relates to methods of treating these diseases by administering a compound or compounds capable of inhibiting monocarboxylate transport and the use of monocarboxylate transport inhibitor compounds in treating such diseases. |
申请人 |
ASTRAZENECA AB |
发明人 |
BANTICK, JOHN, RAYMOND;COOK, IAN, DAVID;DONALD, DAVID, KEITH;HUTCHINSON, RAYMOND;JACKSON, ANDREW, PAUL;JACKSON, CLIVE, GEOFFREY;MURRAY, CLARE, MARGARET;SULLIVAN, MICHAEL |